Compare the 8 manufacturers holding an active US Drug Master File for Degarelix API, with DMF numbers and filing years from the FDA's quarterly DMF list.
Directory listing last reviewed October 2026.
8 manufacturers hold an active Type II Drug Master File for DegarelixAPI, taken from the FDA's quarterly DMF list; 6 of them are listed in this directory. A DMF lets a drug applicant reference the maker's manufacturing data. It is not an FDA approval. Check each manufacturer against the FDA import alert lists before ordering.
| Manufacturer | Location | US DMF | Filed |
|---|---|---|---|
| JYMed Peptide | China (Shenzhen) | 33550 | 2019 |
| Auro Peptides | India (Hyderabad) | 35078 | 2020 |
| Fresenius Kabi iPSUM | Germany | 36499 | 2023 |
| Hybio Pharmaceutical | China | 38904, 41697 | 2023 |
| Apicore (RK Pharma) | USA (East Windsor, NJ) | 40970 | 2024 |
| Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical Co., Ltd. | China | 43215 | 2025 |
Not yet listed in this directory, so we have not reviewed them. Names as printed in the FDA DMF list.
| DMF holder | US DMF | Filed |
|---|---|---|
| Lianyungang Runzhong Pharmaceutical Co Ltd | 35257 | 2020 |
| Jiangsu Hansoh Pharmaceutical Group Co Ltd | 36216 | 2022 |
Request API quotes from several manufacturers at once. Hold a Degarelix DMF and not listed? Add your company.